Daniel Lozano

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial”.

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(20)30844-6

N/A

4.6DataRank · unranked

201 citations

Joaquím Gascón, Fabiana Barreira, Bethania Blum, Igor C. Almeida, Cristina Alonso‐Vega +31 more

New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia

BMJ Open(2021)10.1136/bmjopen-2021-052897

N/A

1.2DataRank · unranked

38 citations

Julio A. Urbina, Sergi Sanz, María‐Jesús Pinazo, Jimy Pinto, Virginia Gonzalez +17 more